Exor, Juventus and the €232 million decline: reading a financial report like a match

When Exor's half-year report, covering the period ending June 30, 2026, was released, football media immediately circled one line: the Juventus stake lost €232 million, falling from €789 million to €557 million. In the same period, Ferrari gained €213 million, rising from €12.037 billion to €12.250 billion. The two items sat side by side on the same page, yet only one was chosen as the headline. I read a financial report the way I read a match: not by looking at the goals, but at the space between the passes. A windowless meeting room forces you to write things down to see what you actually mean. Exor is the Agnelli family's holding company, with controlling stakes in Juventus and Ferrari alongside many other investments. Its half-year report is therefore a summary of an entire portfolio's value, in which Juventus is only a small piece. The most striking feature of this reporting period is not the direction Juventus took, but Exor's shift in accounting method: moving from the equity method to fair-value, mark-to-market accounting for its listed holdings. The old method recorded a share of the subsidiary's profits or losses; the new method simply multiplies the share price by the number of shares held. The consequence is that share-price movements at Juventus and Ferrari now flow directly into Exor's accounts, even if the underlying businesses do not change. Exor itself confirmed that the decline in Juventus reflects stock market performance, not the financial result achieved by the club. To understand the €232 million decline, I had to separate it from sporting pain. Based on my experience following the reporting cycles of football-owning conglomerates, I apply a simple rule: put the two items on the scale. Juventus fell €232 million; Ferrari rose €213 million. The net difference is only about €19 million, almost negligible relative to the portfolio's size. Yet Exor's net asset value per share still fell 3.9% in the first half, while the MSCI World index rose 11.8%. What does that mean? The main reason Exor lagged the market did not come from Juventus, nor from Ferrari. It came from other holdings that were not mentioned on the front page. The media chose Juventus to tell an emotional story; I chose to read the opposite way: Juventus is a marginal variable in Exor's bigger picture. I often redraw diagrams to understand the role of each position on the pitch. In Exor's portfolio, Ferrari is worth €12.250 billion, while Juventus is worth €557 million. That means Juventus is roughly one twenty-second the size of Ferrari. If this were a football team, Juventus would be sitting on the bench of its own parent company. Its movements, even a 29% decline in half a year, remain portfolio noise at group level. But for Juventus fans, that noise is a major signal. The gap between these two readings is where I ask my first question: are we evaluating the club, or are we evaluating shares held by a diversified holding company? Goal.com's article got one crucial detail right: it stressed that this decline is a mark-to-market valuation change, not Juventus's operating result. A club can keep running, keep paying wages, keep buying and selling players normally, while the parent's stake loses value because of investor sentiment. Conversely, a club can lose heavily while its stock rises because of future expectations. Fans read the scoreboard; investors read the valuation board. Those two clocks never run in sync. I record every move as a witness, not as a fan, so I understand that in finance the line between a result and a valuation is as fragile as the line between a goal awarded and a goal disallowed. The point that made me pause longest was not the €232 million decline but John Elkann's statement. He spoke about Exor continuing its disposals and finding suitable owners for companies in the portfolio. To a tactician, that language sounds like a captain saying before a match that he is ready to change the lineup. It does not confirm that Juventus will be sold, but it shows Exor is operating with a portfolio-recycling logic, not a hold-forever logic. Whether Juventus is on the list for new ownership is not stated in the report. That gap is where the biggest risk hides. Tactics do not save a football club, but they tell you where you will die. For Juventus, the potential breaking point is not a defeat on the pitch but the ability to access capital from its major shareholder. In the history of Italian football, big clubs have relied on shareholder capital increases to cover losses and fund the squad. If Exor begins questioning the return on its Juventus investment while Ferrari keeps rising, future funding could tighten. The article provides no data on Juventus's spending or net debt. But I learned long ago that data only has value when it arrives in time for intervention. For Juventus, that moment may be closer than many think. This story also reveals a long-term pattern. Clubs embedded in diversified conglomerates must constantly compete for capital against assets with higher returns. Juventus competes with Inter and Milan on the pitch, but in Exor's boardroom it competes with Ferrari, with other financial holdings, and with the MSCI World index itself. A club can win many matches, but if the value of its asset does not grow according to the parent's expectations, its position in the portfolio will shrink. I am not speaking only about Juventus. This is a structural pressure that any club inside a large conglomerate must face. There is another layer that football people rarely notice: the governance dimension of the Exor–Juventus relationship. Exor is both the controlling shareholder and the party most likely to inject capital into the club when needed. Any capital increase would be classified as a related-party transaction, subject to oversight by Italy's market regulator. Under the equity method, Juventus losses could be recorded directly in Exor's income statement; under fair-value accounting, the movement is simply a share-price difference. This reduces earnings distortion but increases the volatility of corporate disclosures. An investment in a football club now makes the parent's report more sensitive to every trading session on Borsa Italiana. For a listed company, that volatility is not trivial; it can affect how Exor presents results to shareholders and may become a reason to reconsider holding a football asset in the portfolio. One more layer must be peeled away: how football media repackages corporate filings into club news. At every Exor reporting cycle, the €232 million decline will be brought out again, no matter how Juventus plays, no matter whether the club makes a profit or a loss. This is the consequence of the new accounting method: share-price movements enter the report, and the report enters the headlines. For investors, it is valuation information. For fans, it is a story of instability. The same data, two frames of reference. A writer must choose one frame before typing, otherwise he will tell a story that is emotionally true but factually misleading. The blind spot in this story is the framing itself. A valuation decline is narrated as if Juventus were burning through cash; in reality, Juventus is a small asset in a conglomerate undergoing restructuring. The paradox is that when a club is owned by a large conglomerate, sporting success is no longer the only measure. Exor must compare Juventus with Ferrari, with other investments, with the MSCI World. Juventus is playing on a pitch where the opponents are not Inter or Milan but the return on equity of a carmaker. A tactical diagram is like a landslide map: it tells you where not to stand. For fans, the place not to stand is where every financial problem is blamed on pitch form; for investors, the place not to stand is where a falling share price is mistaken for an imminent collapse. The €232 million decline could be a buying opportunity for a long-term investor who believes the market is undervaluing Juventus's football assets. That is a perspective rarely seen in fan forums. At 59, I understand that winning matters less than explaining why you win. Exor's report does not say Juventus is about to be sold, nor does it say Juventus is healthy. It only says that the value of the club's stake in the eyes of the parent has fallen, and that the club's position in the portfolio is becoming increasingly marginal. Juventus's real match does not take place on the weekend. It takes place in each future Exor report, in every time Elkann mentions disposals, in every decision about a capital increase. I will track those signals, because they reveal where Juventus stands on the diagram of its own parent company. And when the new sporting season begins, I will remind myself not to confuse the applause in the stands with the real value of an asset.